Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LAM NGUYEN CHU

Allopathic & Osteopathic Physicians Obstetrics & Gynecology

NPI
1497914816
CMS profile
249804
Location
HOUSTON, TX

General Payments · PY2018–2024

$3,205.17

  • Reported across 177 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$305.59

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $305.59 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Biogen, Inc. $77.24 3
Astellas Pharma US Inc $73.72 4
Sumitomo Pharma America, Inc. $47.02 2
PFIZER INC. $40.32 2
MAYNE PHARMA COMMERCIAL LLC $25.94 1
Organon LLC $21.33 1
ABBVIE INC. $20.02 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $562.31 32
PY2019 $576.89 36
PY2020 $509.56 31
PY2021 $357.05 20
PY2022 $254.97 14
PY2023 $638.80 30
PY2024 $305.59 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $20.02 10/29/2024 Food and Beverage Undisputed 01/23/2026 1103470885 CMS
Astellas Pharma US Inc $18.50 02/19/2024 Food and Beverage Undisputed 01/23/2026 1139265570 CMS
Astellas Pharma US Inc $17.03 09/17/2024 Food and Beverage Undisputed 01/23/2026 1139407149 CMS
Astellas Pharma US Inc $18.48 10/03/2024 Food and Beverage Undisputed 01/23/2026 1139410253 CMS
Astellas Pharma US Inc $19.71 11/04/2024 Food and Beverage Undisputed 01/23/2026 1139434410 CMS
Biogen, Inc. $21.55 03/20/2024 Food and Beverage Undisputed 01/23/2026 1104822626 CMS
Biogen, Inc. $27.03 10/21/2024 Food and Beverage Undisputed 01/23/2026 1104830622 CMS
Biogen, Inc. $28.66 12/16/2024 Food and Beverage Undisputed 01/23/2026 1104848102 CMS
MAYNE PHARMA COMMERCIAL LLC $25.94 02/14/2024 Food and Beverage Undisputed 01/23/2026 1154680983 CMS
Organon Llc $21.33 05/15/2024 Food and Beverage Undisputed 01/23/2026 1136235721 CMS
PFIZER INC. $20.16 01/17/2024 Food and Beverage Undisputed 01/23/2026 1131057080 CMS
PFIZER INC. $20.16 11/25/2024 Food and Beverage Undisputed 01/23/2026 1131196128 CMS
Sumitomo Pharma America, Inc. $24.54 01/30/2024 Food and Beverage Undisputed 01/23/2026 1148838323 CMS
Sumitomo Pharma America, Inc. $22.48 02/26/2024 Food and Beverage Undisputed 01/23/2026 1148838325 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.